Just a quick post to let everyone know I have updated the Synta Pharma $SNTA webpage to reflect my notes from their presentation at the BIO CEO conference on 2/14/2011.
As I mentioned last week, SNTA saw a one day spike of about 15% the day after I bought in at $4.55. If I had accumulated more than a starter position, I probably would have sold some for the quick profit (it has since drifted back down into the $4's). But I want to be long SNTA going into the next data release from the Ganetespib/STA-9090 HSP90 inhibitor p2 trial in non-small cell lung cancer (NCSLC) which is coming up on 2/26/2011.
Until then, thanks for checking out the blog and website!
As I mentioned last week, SNTA saw a one day spike of about 15% the day after I bought in at $4.55. If I had accumulated more than a starter position, I probably would have sold some for the quick profit (it has since drifted back down into the $4's). But I want to be long SNTA going into the next data release from the Ganetespib/STA-9090 HSP90 inhibitor p2 trial in non-small cell lung cancer (NCSLC) which is coming up on 2/26/2011.
Until then, thanks for checking out the blog and website!
RSS Feed
